RPS15

RPS15

Introduction

Rps15 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@role2022]
<h3>RPS15</h3> [@rps2021]
<table> [@molecular2020]
<tr><th>Full Name</th><td>Ribosomal Protein S15</td></tr> [@rps2019]
<tr><th>Chromosomal Location</th><td>19p13.3</td></tr> [@therapeutic2018]
<tr><th>NCBI Gene ID</th><td>[6209](https://www.ncbi.nlm.nih.gov/gene/6209)</td></tr> [@rps2017]
<tr><th>Ensembl ID</th><td>[ENSG00000149091](https://www.ensembl.org/Homo_sapiens/ENSG00000149091)</td></tr> [@clinical2016]
<tr><th>UniProt ID</th><td>[P62271](https://www.uniprot.org/uniprot/P62271)</td></tr> [@rps2021a]
<tr><th>Associated Diseases</th><td>[Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr> [@ribosomal2020]
</table>
</div>

Overview

RPS15 (Ribosomal Protein S15) is a 145-amino acid protein component of the 40S ribosomal subunit. It plays a critical role in the decoding center of the ribosome and is essential for accurate mRNA translation. RPS15 is one of the most frequently mutated ribosomal proteins in human disease, with mutations causing Diamond-Blackfan anemia (DBA), and mutations observed in chronic lymphocytic leukemia (CLL) and ALS.

Protein Structure

RPS15 is a small basic protein (pI ~11.5) located at the head of the 40S subunit in the decoding center. Key structural features include:

RPS15

Introduction

Rps15 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@role2022]
<h3>RPS15</h3> [@rps2021]
<table> [@molecular2020]
<tr><th>Full Name</th><td>Ribosomal Protein S15</td></tr> [@rps2019]
<tr><th>Chromosomal Location</th><td>19p13.3</td></tr> [@therapeutic2018]
<tr><th>NCBI Gene ID</th><td>[6209](https://www.ncbi.nlm.nih.gov/gene/6209)</td></tr> [@rps2017]
<tr><th>Ensembl ID</th><td>[ENSG00000149091](https://www.ensembl.org/Homo_sapiens/ENSG00000149091)</td></tr> [@clinical2016]
<tr><th>UniProt ID</th><td>[P62271](https://www.uniprot.org/uniprot/P62271)</td></tr> [@rps2021a]
<tr><th>Associated Diseases</th><td>[Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr> [@ribosomal2020]
</table>
</div>

Overview

RPS15 (Ribosomal Protein S15) is a 145-amino acid protein component of the 40S ribosomal subunit. It plays a critical role in the decoding center of the ribosome and is essential for accurate mRNA translation. RPS15 is one of the most frequently mutated ribosomal proteins in human disease, with mutations causing Diamond-Blackfan anemia (DBA), and mutations observed in chronic lymphocytic leukemia (CLL) and ALS.

Protein Structure

RPS15 is a small basic protein (pI ~11.5) located at the head of the 40S subunit in the decoding center. Key structural features include:

• RNA-binding domain: Facilitates codon-anticodon base pairing
• RPS19-binding site: Forms heterodimer with RPS19 for ribosome assembly
• Nucleolar localization signal: Targets protein to nucleolus for ribosome biogenesis

Crystal Structure

The crystal structure of the 40S ribosome (PDB: 4KJP) shows RPS15 positioned at the mRNA channel entrance, where it interacts with:

• mRNA nucleotides at positions +2 to +4
• 18S rRNA
• RPS19 and RPS24

Normal Function

Ribosomal Function

As a 40S ribosomal protein, RPS15 contributes to:

Extra-Ribosomal Functions

RPS15 has additional cellular roles:

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

RPS15 has emerged as relevant to ALS pathogenesis:

• Somatic mutations: RPS15 mutations identified in sporadic ALS motor neurons
• Ribosomal dysfunction: Global translation impairment in ALS
• Nucleolar stress: Nucleolar alterations in ALS postmortem tissue
• p53 activation: Ribosomal stress may contribute to p53-dependent cell death

Parkinson Disease

Emerging evidence links RPS15 to PD pathophysiology:

• α-Synuclein translation: Ribosomal binding to alpha-synuclein mRNA may be dysregulated
• Dopaminergic neuron vulnerability: Ribosomal stress affects dopaminergic neurons
• Mitochondrial-ribosomal cross-talk: Impaired coordination between mitochondrial function and translation
• Autophagy-ribophagy pathway: Aberrant ribosome degradation in PD models

Alzheimer Disease

Ribosomal dysfunction accompanies AD pathology:

• Global translation reduction: eIF2α hyperphosphorylation suppresses translation
• Synaptic protein loss: Ribosomes are translationally impaired in synapses
• Memory deficits: Correlate with translation defects

Gene Regulation

Transcriptional Regulation

RPS15 expression is regulated through multiple mechanisms:

Post-Transcriptional Regulation

• 5'UTR structure: Internal ribosome entry site (IRES) allows cap-independent translation
• mRNA stability: AU-rich elements in 3'UTR regulate mRNA half-life
• microRNA targeting: Several miRNAs (miR-23a, miR-146a) target RPS15

Translational Control

RPS15 translation is sensitive to:

• mTOR signaling pathway
• eIF2α phosphorylation state
• Ribosome availability
• Cellular energy status

Protein Structure Details

RPS15 (145 amino acids, ~15 kDa) possesses distinct structural features:

Primary Structure

• N-terminal domain (1-45): Basic region involved in RNA binding
• Central domain (46-100): Contains the decoding center interaction interface
• C-terminal domain (101-145): Acidic tail involved in protein-protein interactions

Tertiary Structure

The crystal structure reveals:

• Alpha-helical fold with characteristic ribosomal protein topology
• Surfaceexposed residues for rRNA interaction
• Conserved motifs for MDM2 binding

Animal Models

Mouse Models

• Rps15 heterozygous mice: Viable with mild ribosome biogenesis defects
• Rps15 conditional knockouts: Tissue-specific deletion studies
• Transgenic overexpression: Modeling cancer and ribosomal stress

Key Findings

• Rps15 haploinsufficiency causes p53 activation
• Ribosomal stress triggers cell cycle arrest
• Developmental defects in complete knockout
• Motor neuron-specific deletion leads to ALS-like phenotype

Zebrafish Models

• Morpholino knockdowns show developmental defects
• Motor neuron axonal outgrowth impaired

Therapeutic Strategies

| Approach | Description | Status |
|----------|-------------|--------|
| Ribosome modulators | Enhance translation fidelity | Preclinical |
| p53 modulators | Inhibit p53-mediated cell death | Research |
| Ribophagy inhibitors | Block aberrant ribosome degradation | Early research |
| eIF2α phosphatase inhibitors | Restore global translation | Preclinical |
| Antisense oligonucleotides | Target mutant RPS15 transcripts | Research |

Drug Development

Clinical Significance

Biomarker Potential

• RPS15 expression levels correlate with disease progression
• Cerebrospinal fluid RPS15 as potential biomarker
• Serum ribosomal protein levels in neurodegenerative diseases

Diagnostic Applications

• RPS15 mutations as diagnostic marker in CLL
• Ribosomal stress markers for ALS diagnosis

Research Directions

References

See Also

• [Ribosomal Proteins Family](/proteins/ribosomal-proteins-family)
• [ALS Gene Ontology](/diseases/amyotrophic-lateral-sclerosis)
• [Translation Machinery](/mechanisms/translation-machinery)
• [p53 Pathway](/mechanisms/p53-apoptosis-pathway)
• [Ribosomopathies](/diseases/ribosomopathies)